OPEN END-TURBO-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000HG3R640

Real-time Bid/Ask 11:01:56 07/05/2024 BST
1.42 EUR / 1.43 EUR +2.52% Intraday chart for OPEN END-TURBO-OPTIONSSCHEIN - STRYKER CORP.
Current month-7.95%
1 month-14.20%
Date Price Change Volume
07/05/24 1.41 +1.44% 0
06/05/24 1.39 -2.11% 0
03/05/24 1.42 +1.43% 0
02/05/24 1.4 -7.28% 0
30/04/24 1.51 -0.66% 0

Delayed Quote Börse Stuttgart

Last update May 07, 2024 at 10:38 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer HSBC
WKN HG3R64
ISINDE000HG3R640
Date issued 08/06/2022
Strike 176.5 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.71
Lowest since issue 0.34
Spread 0.01
Spread %0.70%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
325.5 USD
Average target price
372.4 USD
Spread / Average Target
+14.39%
Consensus